Impact of Timing of PD Assessments on Measures of Platelet Reactivity in Patients Undergoing PCI Treated With Cangrelor
NCT04668495 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17
Last updated 2021-09-14
Summary
This study is assessing the impact of timing of PD assessments on measures of platelet reactivity in patients undergoing PCI treated with cangrelor.
Conditions
Sponsors & Collaborators
-
Chiesi Farmaceutici S.p.A.
collaborator INDUSTRY -
University of Florida
lead OTHER
Principal Investigators
-
Dominick Angiolillo, MD, PhD · Professor of Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-28
- Primary Completion
- 2021-04-04
- Completion
- 2021-07-20
Countries
- United States
Study Locations
More Related Trials
-
Cangrelor Prasugrel Transition Study
NCT01852019 ·Status: COMPLETED ·Phase: PHASE2
-
In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
NCT02081443 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Demonstrate the Efficacy of Cangrelor
NCT00305162 ·Status: TERMINATED ·Phase: PHASE3
-
Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
NCT01823185 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:
NCT02065479 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
NCT01156571 ·Status: COMPLETED ·Phase: PHASE3
-
Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity
NCT01493999 ·Status: COMPLETED ·Phase: PHASE4
-
CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI
NCT03296540 ·Status: COMPLETED ·Phase: PHASE4
-
Maintenance of Platelet Inhibition With Cangrelor
NCT00767507 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
NCT06228456 ·Status: RECRUITING ·Phase: PHASE4
-
Platelet Function Assessment for Atherothrombotic Patients
NCT00513149 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
NCT02548611 ·Status: TERMINATED ·Phase: PHASE4
-
Prasugrel Re-load Strategies
NCT01201772 ·Status: COMPLETED ·Phase: PHASE4
-
IU Health Krannert Personalized Medicine Study
NCT02955121 ·Status: TERMINATED ·Phase: NA
-
Continuous Clopidogrel Dose Adjustment in Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity
NCT02096419 ·Status: COMPLETED ·Phase: PHASE4
-
Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)
NCT01463150 ·Status: COMPLETED ·Phase: PHASE4
-
Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI
NCT02469740 ·Status: COMPLETED ·Phase: PHASE4
-
Dual-antiplatelet Therapy Strategies for Elective PCI in a Real-world Setting
NCT05559918 ·Status: RECRUITING
-
75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
NCT00140465 ·Status: COMPLETED ·Phase: PHASE4
-
Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).
NCT01109784 ·Status: COMPLETED ·Phase: PHASE3
-
Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)
NCT07025148 ·Status: RECRUITING ·Phase: PHASE4
-
Pharmacological Effects of Crushing Prasugrel in STEMI Patients
NCT02212028 ·Status: COMPLETED ·Phase: PHASE4
-
Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome
NCT01774838 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
NCT00644657 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenetic and Pharmacokinetic Study of Clopidogrel
NCT01968499 ·Status: COMPLETED